A Single Center, Single Arm Clinical Study on the Treatment of Advanced Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations and Failed EGFR TKIs With the Combination of Enrotinib and Paclitaxel Monoclonal Antibody

Conditions:   Lung Cancer;   TKI Resistance;   EGFR Sensitive Mutation;   Anlotinib;   Pianzumab Interventions:   Drug: Anlotinib;   Drug: Penpulimab Sponsors:   Degan Lu;   Wu Jieping Medical Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials